Attendees:
+ND Capital
3B Future Health Fund
3i Group plc
6465 Therapeutics
AATec Medical GmbH
AbbVie Ventures
AbbVie, Inc.
abcDNA GmbH
Abivax SA
Accequa
AdBio Partners
AdCab
ADOCIA
Adularia AG
Advantary Capital Partners
AEC Partners
AFK & Partners Asset Management LLC
Akribion Therapeutics GmbH
Alchemab Therapeutics Ltd
Alipheron AG
Allegro N.V.
Alphion UG
Alternative Assets Finance
Alzinova AB
Ampleia
Amplio Pharma
Amporin Pharmaceuticals AG
AMR Action Fund GP GmbH
Anaka Pharmaceuticals, Inc.
Anaveon AG
Andera Partners SA
Angelini Ventures S.p.A.
Anima Biotech Inc.
Apollo Health Ventures
ARCHIMED
Argenx
Argobio Studio
Asahi Kasei Europe GmbH
Asian Innovation & Finance Center (AIFC)
Asklepios Advisors
Astellas Pharma Europe Ltd.
Astr Partners
AstraZeneca
Astrivax Therapeutics N.V.
ATGN Consulting
Atlas Capital Ventures LLC
AudioCure Pharma GmbH
Aukera Therapeutics AG
AurorA Science Srl
Avance Life Sciences
Awen GmbH
Baker McKenzie
BaseLaunch
Bayern Kapital GmbH
BB Biotech AG
Beneficious LLC
BeOne Medicines I GmbH
Bergaud & Partners
BERNINA BioInvest Ltd.
Bio Med Gene Ventures
Biodelphis Therapeutics SA
BioMedPartners AG
BiomedVC AG
BioPharma Advisory
Biopôle SA
Bioqube Ventures
BIOSTART Consulting GmbH
biotx.ai GmbH
Biovance Capital
Biovision Ventures
Bioxodes SA
BlackRock
Blackstone Group
Bloomberg Intelligence
Bloomberg LP
BNP Paribas Asset Management
Boehringer Ingelheim International GmbH
Boehringer Ingelheim Venture Fund GmbH
BOHE Angel Fund
Borea Therapeutics S.r.l.
Bpifrance
Brainomix Limited
Brandon Capital Partners
Breakline Resolution
Brenus Pharma
Breslin AG
BSM Biotech Holding GmbH
Business Angels Switzerland
Caedo Oncology AS
Caladrix Pty Ltd
Cancer Research and Biotechnology AG
Cancer Research Horizons
Canton of Basel-Stadt
Capital Grand Est
CARTemis Therapeutics GmbH
Cati Therapeutics
CB Therapeutics
CD4 Therapeutics GmbH
CDP Venture Capital SGR S.p.A.
CDR-Life, Inc.
CellProthera SAS
Cereus Biosciences
CheckBrain Therapeutics
Chugai Venture Fund, LLC
Claris Ventures
ClearideBio Therapeutics AG
Cohesion Bureau
Connext Co., Ltd.
Convergence Partners
Convert Pharmaceuticals SA
Corinthian Financial Management Ltd
Coulter Partners
Covington & Burling LLP
CPTx GmbH
CureGBM
Curlim
DeBere Partners Limited
Debiopharm International SA
DeepTech & Climate Fonds
Dementia Discovery Fund 2 L.P. (SV Health Investors)
Diamante Società Benefit Srl
Digital Networks PLC
docdok.health Ltd.
Earlybird Health Management GmbH & Co. KG
École polytechnique fédérale de Lausanne (EPFL)
Eight Bridges
Eli Lilly and Company
Ennovate Pharma
Ervimmune
ESC Advisors
European Braintech Fund
European Investment Bank
European Investment Fund
Evernow Publishing Ltd, publisher of MedNous
Evidenze
Evotec AG
Expert Systems, Inc.
ExpreS2ion Biotech Holding AB
F. Hoffmann-La Roche AG
FimmCyte AG
Finanz und Wirtschaft
FINNCURE Ltd.
FluoSphera SA
Fontaine Capital
Forbion
Forta Bio, Inc.
Fortlane Partners GmbH
Forty51 Ventures AG
Forvis Mazars
FoRx Therapeutics AG
Fraser Partners
FreeMind Group
Fresenius Ventures
Fund+
Futurewave AG
Galimedix Therapeutics, Inc.
Generation Fund Life Sciences Fund I
Genevant Sciences GmbH
Genius Search GmbH & Co. KG
Genmab A/S
Gero Pte. Ltd
Gibela Therapeutics GmbH
GIBF
Gilde Healthcare Partners BV
Gimv
GlobalClose Alliances (GCA)
GOLDTRACK Ventures GmbH
GreenBone Ortho S.p.A.
GSK
Gubra Ventures
Gyre Therapeutics, Inc.
Hadean Ventures
Hansa Biopharma AB
Health Innovation Capital
HealthCap
HeartBeat.bio AG
Helsinn Healthcare SA
HEPHAISTOS-Pharma
HGF Limited
High-Tech Gründerfonds Management GmbH
HiRO
HK WinHealth Pharma Group
Hong Kong Economic and Trade Office, Berlin (HKETO)
Hong Kong Exchanges and Clearing Limited (HKEX)
Hong Kong Trade Development Council
HOX Therapeutics Ltd.
i&i Biotech Fund I SCSp
IAG, Image Analysis Group
IAMA Therapeutics S.r.l.
ICF Consult Switzerland
ICOSA Group
Immunethep, S.A.
Indaco Venture Partners SGR S.p.A.
Industrifonden
InflaRx GmbH
iniuva GmbH
Innovestor Life Science Ltd.
Innunity Therapeutics
INOGROUP GmbH
Institute of Molecular & Clinical Ophthalmology Basel (IOB)
Intercontinental Capital
Intermediate Capital Group PLC
Inveready Asset Management S.G.E.I.C., S.A.
InvestHK
IPF Partners
iQure Pharma Inc.
IQVIA
Italian Angels for Growth (IAG)
IXICO plc
J.P. Morgan
Jeito Capital
JFG Life Sciences Stiftung der Universität Basel
Johnson & Johnson Innovation LLC
JT Advisory
Justin Stindt Consulting AG
Kerna Ventures
kez.biosolutions GmbH
KG Capital Management LLC.
KHAN Fund
Kinled Holding Limited
Kondree
KPMG Paris
KreaMedica Holdings Inc.
Ksilink
Kurma Partners
Landmark BioVentures AG
Laverock Therapeutics Ltd.
Leads To Development SAS
LifeArc Ventures
LifeCare Partners GmbH
Lifespan Vision Ventures LLC
LIMAA Technologies GmbH
LMU Munich
Loma Therapeutics
Lonza Group AG
Lucera GmbH
Lynx Financial Hong Kong Ltd.
Mabqi S.A.S.
Maeve Therapeutics B.V.
MARATHON Beteiligungs AG
MC Services AG
Meddenovo Drug Design SAS
Medicxi
MedinCell S.A.
MEDiSTRAVA
Meliodays Medical GmbH
Merck KGaA
Mérieux Equity Partners
Metaimmune Therapeutics
Micreos Pharma
MIG Capital AG
Mirabaud & Cie SA
Modi Ventures
MONCYTE Health
Move Venture Consulting
MultivisionDx
Mwyngil Therapeutics
Myria Biosciences AG
Nanolynx Biologics AG
NatIgGs GmbH
Neolie Science Partners
Nerai Bioscience AG
Neumirna Therapeutics ApS
Neurimmune AG
NeutroGen Therapeutics GmbH
New Science Fund
Nextech
NG Bio LTD
Nœtica Pharma
Nomal Therapeutics
Novac BiotechBD
Novartis BioMedical Research
Novartis Oncology
Novartis Pharma AG
Novartis Venture Fund
Novateur Ventures Inc
Novo Holdings A/S
Novo Nordisk A/S
NRW.Venture
NRx Pharmaceuticals, Inc.
NS Pharma, Inc.
Nucleome Therapeutics Ltd.
Nucleus Network Ltd
NXI Therapeutics AG
NxR Biotechnologies GmbH
O11 biomedical GmbH
OGD2 Pharma
OKG Capital LP
Okomera
Omega Funds
Oncode Accelerator
Oncostellae
One04 Therapeutics
Oppenheimer & Co. Inc.
Organon
Origenis GmbH
Otsuka Pharmaceutical Europe Ltd.
Oxford Science Enterprises plc
OxSonics
Panakès Partners SGR SpA
Panosome GmbH
Parexel International
Partners Group
Peppermint VenturePartners GmbH
Peregrine Ventures
Perseo Pharma AG
Persica Pharmaceuticals Limited
PharmCube
PharmNovo AB
Playground Global
Procavea Biotech AG
PSCC
PulseSight Therapeutics SAS
PureDEL
Pureos Bioventures
QUASAR Therapeutics GmbH
Rahim Invest SÀRL
Real Web SA Luxembourg
Reconnect Labs AG
Recordati Pharma GmbH
Redalpine Venture Partners AG
Rhea BioVentures
Roche Venture Fund
Ropes & Gray LLP
RV Invest GmbH
Salus Partners SA
Sappiens SAS
Schwarz Financial Communication
SCI Ventures LLC
Secarna Pharmaceuticals GmbH & Co. KG
SEDGE Ventures LLC
Seekyo Therapeutics
Selonterra, Inc.
SEQENS
Serca Pharmaceuticals AS
Serenatis Bio Ltd.
Servier Ventures
Seventure Partners
Shanda Grab Ventures Limited
Sirona Capital
Skyvor Medical AG
Sobi
Sofinnova Partners
Solgate GmbH
SPARK Finland
SpliceBio, S.L.
Sprim Global Investments
Staatz BD & Strategy
StemInov SAS
Stifel
Strategic Transactions Advisory AG
Strike Pharma AB
Sunstone Life Science Ventures
Superlab Suisse AG
Swiss Biotech Association
SWISS IMMUNE | SWISS Orphan EDC AG
Switchkine SA
SymphoRNA
SynAct Pharma
Synameta Therapeutics
T-CURX GmbH
T-Therapeutics Ltd.
TargImmune Therapeutics AG
Teitur Trophics ApS
Terra Quantum AG
TFS HealthScience
The Fulford Group Ltd.
Therakles Pharmaceuticals AG
TheraVenture GmbH
Tigermed
TiltBio Inc.
TMA
TOLREMO Therapeutics AG
Tribune Therapeutics AB
Tridek-One Therapeutics
Truffle Capital
Tuari Therapeutics GmbH
TVM Capital Life Science
UBS AG
UCB Ventures
UI Investissement
Umlaut.bio GmbH
Unison Innovations
Universite Paris-Saclay
University of Zurich
UPyTher B.V.
UZH Life Sciences Fund, AG
VALANX Biotech GmbH
Valink Therapeutics
Valor Management
VBW Holdings, LLC
Venture Valuation VV AG
Versant Ventures
Vesalius Biocapital IV Partners SàRL
Vi Partners AG
Viopas Venture Consulting GmbH
Vogel BioC
VS Principal Investments AG
VU Venture Partners
VUS Genetics
Wellington Partners
WG Partners LLP
WuXi AppTec
XGEN Venture SGR S.p.A.
Xlife Sciences AG
XOventure
YAYA Capital
YGION Biomedical GmbH
Ysios Capital
Zinc VC
ZZZ Sachs Testin
Last updated: October 6, 2026